Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

BioRestorative Therapies, Inc. (BRTX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Sep-30-22Jun-30-22Mar-31-22Sep-30-21Jun-30-21Mar-31-21Sep-30-20
   10-Q10-Q10-Q10-Q10-Q10-Q10-Q10-Q
Net income  -3.0-4.7-4.7-4.8-4.2-4.1-15.7-0.8
Depreciation and amortization   0.00.00.00.00.00.00.0
Stock-based compensation  0.30.06.40.1   0.2
Change in working capital   [+] 0.10.30.10.30.00.30.1
Other operating activities   3.1-3.33.13.33.314.50.0
Cash from operations  -2.7-1.5-1.3-1.6-0.6-0.7-0.8-0.5
   
Capital expenditures  0.00.0-0.1-0.10.00.00.00.0
Purchases of short-term investments   -9.9      
Cash from investing  0.0-9.9-0.1-0.10.00.00.00.0
   
Other cash from financing        0.30.4
Cash from financing  0.00.00.00.00.00.00.30.4
   
Free cash flow  -2.7-1.4-1.4-1.7-0.6-0.7-0.8-0.5
        Per share (diluted)  ($0.68)($0.39)($0.38)($0.48)($0.75)($0.93)($1.11)($1.31)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy